BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of September 10, 2026, BRTX trades at $2.71 with a market cap of $3.87M and a P/E ratio of -1.82. BRTX moved +2.75% today. Year to date, BRTX is -88.34%; over the trailing twelve months it is -91.27%. Its 52-week range spans $2.61 to $51.00. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest BRTX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $2.71 |
| Market Cap | $3.87M |
| P/E Ratio | -1.82 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $51.00 |
| 52-Week Low | $2.61 |
| Volume | 47.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $359.70K |
| Net Income | $-14.24M |
| Gross Margin | 93.37% |
BRTX analyst coverage data. Average price target: $0.00.